Drug
Propylene Glycol
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Eye Irritation | 598 | 81.5 | 103.4 | signal |
| 2 | Eye Discharge | 95 | 70.5 | 73.0 | signal |
| 3 | Appendicitis | 85 | 69.3 | 71.5 | signal |
| 4 | Ventricular Fibrillation | 86 | 58.5 | 60.3 | signal |
| 5 | Eye Pain | 354 | 48.5 | 55.4 | signal |
| 6 | Cardiogenic Shock | 82 | 43.4 | 44.7 | signal |
| 7 | Ocular Hyperaemia | 261 | 42.2 | 46.5 | signal |
| 8 | Eye Pruritus | 178 | 40.8 | 43.5 | signal |
| 9 | Ocular Discomfort | 49 | 34.0 | 34.6 | signal |
| 10 | Dry Eye | 217 | 33.8 | 36.6 | signal |
| 11 | Lacrimation Increased | 115 | 29.0 | 30.2 | signal |
| 12 | Incorrect Route Of Product Administration | 64 | 28.7 | 29.4 | signal |
| 13 | Bacterial Infection | 64 | 26.0 | 26.6 | signal |
| 14 | Multiple Organ Dysfunction Syndrome | 92 | 24.8 | 25.7 | signal |
| 15 | Hyperlipidaemia | 36 | 22.6 | 22.9 | signal |
| 16 | Neuralgia | 71 | 22.1 | 22.6 | signal |
| 17 | Ascites | 86 | 22.0 | 22.7 | signal |
| 18 | Vision Blurred | 323 | 17.8 | 20.0 | signal |
| 19 | Ulcer | 37 | 17.5 | 17.7 | signal |
| 20 | Gastroenteritis | 33 | 17.0 | 17.2 | signal |
| 21 | Blood Test Abnormal | 31 | 16.6 | 16.8 | signal |
| 22 | Photophobia | 41 | 16.5 | 16.8 | signal |
| 23 | Gout | 39 | 16.3 | 16.6 | signal |
| 24 | End Stage Renal Disease | 39 | 15.9 | 16.2 | signal |
| 25 | Eye Inflammation | 19 | 15.2 | 15.3 | signal |
| 26 | Chronic Obstructive Pulmonary Disease | 105 | 15.2 | 15.7 | signal |
| 27 | Aspiration | 21 | 14.6 | 14.7 | signal |
| 28 | Eosinophilia | 33 | 14.2 | 14.4 | signal |
| 29 | Full Blood Count Abnormal | 19 | 13.6 | 13.6 | signal |
| 30 | Eyelid Oedema | 20 | 12.9 | 12.9 | signal |
| 31 | Presyncope | 39 | 12.1 | 12.3 | signal |
| 32 | Eye Infection | 18 | 12.1 | 12.1 | signal |
| 33 | Hypercholesterolaemia | 15 | 11.8 | 11.9 | signal |
| 34 | Hyponatraemia | 87 | 11.6 | 12.0 | signal |
| 35 | Blood Cholesterol Increased | 69 | 11.1 | 11.4 | signal |
| 36 | Eye Swelling | 54 | 11.0 | 11.2 | signal |
| 37 | Lower Respiratory Tract Infection | 66 | 11.0 | 11.2 | signal |
| 38 | Obstructive Airways Disorder | 16 | 10.8 | 10.8 | signal |
| 39 | Micturition Urgency | 16 | 10.6 | 10.7 | signal |
| 40 | Upper Respiratory Tract Infection | 65 | 10.6 | 10.8 | signal |
| 41 | Stress | 98 | 10.2 | 10.6 | signal |
| 42 | Expired Product Administered | 44 | 10.0 | 10.1 | signal |
| 43 | Product Quality Issue | 169 | 9.4 | 10.0 | signal |
| 44 | Pulmonary Embolism | 108 | 8.5 | 8.8 | signal |
| 45 | Sleep Disorder | 77 | 8.3 | 8.5 | signal |
| 46 | Iron Deficiency Anaemia | 10 | 8.2 | 8.2 | signal |
| 47 | Dry Mouth | 85 | 7.9 | 8.1 | signal |
| 48 | Thrombosis | 80 | 7.5 | 7.6 | signal |
| 49 | Diabetes Mellitus | 73 | 7.2 | 7.3 | signal |
| 50 | Sputum Discoloured | 9 | 7.2 | 7.2 | signal |
| 51 | Sepsis | 104 | 7.0 | 7.2 | signal |
| 52 | Joint Injury | 19 | 6.7 | 6.7 | signal |
| 53 | Abdominal Distension | 92 | 6.7 | 6.8 | signal |
| 54 | Intraocular Pressure Increased | 11 | 6.4 | 6.5 | signal |
| 55 | Transaminases Increased | 19 | 6.4 | 6.5 | signal |
| 56 | Intentional Product Misuse | 73 | 6.3 | 6.5 | signal |
| 57 | Cataract | 49 | 6.2 | 6.3 | signal |
| 58 | Liver Function Test Increased | 17 | 6.0 | 6.0 | signal |
| 59 | Swelling | 74 | 6.0 | 6.1 | signal |
| 60 | General Physical Health Deterioration | 90 | 5.9 | 6.1 | signal |
| 61 | Poor Quality Product Administered | 8 | 5.9 | 5.9 | signal |
| 62 | Productive Cough | 37 | 5.9 | 5.9 | signal |
| 63 | Seasonal Allergy | 11 | 5.9 | 5.9 | signal |
| 64 | Drug Intolerance | 74 | 5.8 | 5.9 | signal |
| 65 | Nasal Congestion | 44 | 5.7 | 5.7 | signal |
| 66 | Eye Haemorrhage | 10 | 5.6 | 5.6 | signal |
| 67 | Pulmonary Mass | 11 | 5.6 | 5.6 | signal |
| 68 | Dermatitis Atopic | 36 | 5.4 | 5.5 | signal |
| 69 | Vitreous Floaters | 7 | 5.4 | 5.4 | signal |
| 70 | Wheezing | 41 | 5.2 | 5.3 | signal |
| 71 | Drug Toxicity | 9 | 4.9 | 4.9 | signal |
| 72 | Blood Creatinine Increased | 41 | 4.7 | 4.8 | signal |
| 73 | Coronary Artery Disease | 19 | 4.7 | 4.7 | signal |
| 74 | Pleural Effusion | 37 | 4.6 | 4.6 | signal |
| 75 | Product Use Complaint | 9 | 4.4 | 4.4 | signal |
| 76 | Visual Acuity Reduced | 19 | 4.3 | 4.3 | signal |
| 77 | Sinus Disorder | 11 | 4.2 | 4.2 | signal |
| 78 | Transient Ischaemic Attack | 18 | 4.0 | 4.0 | signal |
| 79 | Drug Hypersensitivity | 102 | 3.9 | 4.1 | signal |
| 80 | Pulmonary Fibrosis | 10 | 3.9 | 3.9 | signal |
| 81 | Device Use Issue | 9 | 3.9 | 3.9 | signal |
| 82 | Asthma | 58 | 3.9 | 4.0 | signal |
| 83 | Madarosis | 6 | 3.9 | 3.9 | signal |
| 84 | Somnolence | 103 | 3.9 | 4.0 | signal |
| 85 | Cardiovascular Disorder | 13 | 3.8 | 3.8 | signal |
| 86 | Eye Disorder | 16 | 3.7 | 3.7 | signal |
| 87 | Musculoskeletal Stiffness | 42 | 3.6 | 3.6 | signal |
| 88 | Lactic Acidosis | 15 | 3.5 | 3.5 | signal |
| 89 | Skin Reaction | 6 | 3.2 | 3.2 | signal |
| 90 | Covid-19 Pneumonia | 5 | 3.2 | 3.2 | signal |
| 91 | Febrile Neutropenia | 27 | 3.1 | 3.1 | signal |
| 92 | Product Administration Error | 8 | 3.0 | 3.0 | signal |
| 93 | Salivary Hypersecretion | 4 | 3.0 | 3.0 | no signal |
| 94 | Hunger | 5 | 2.8 | 2.8 | signal |
| 95 | Skin Haemorrhage | 5 | 2.6 | 2.6 | no signal |
| 96 | Pulmonary Arterial Hypertension | 5 | 2.6 | 2.6 | no signal |
| 97 | Product Packaging Issue | 3 | 2.4 | 2.4 | no signal |
| 98 | Knee Operation | 3 | 2.3 | 2.3 | no signal |
| 99 | Blood Glucose Abnormal | 5 | 2.0 | 2.0 | no signal |
| 100 | Product Taste Abnormal | 3 | 1.7 | 1.7 | no signal |
| 101 | Incorrect Route Of Drug Administration | 8 | 1.7 | 1.7 | no signal |
| 102 | Drug Dispensing Error | 3 | 1.5 | 1.5 | no signal |
| 103 | Wrong Technique In Product Usage Process | 34 | 1.3 | 1.3 | no signal |
| 104 | Product Complaint | 4 | 1.2 | 1.2 | no signal |
| 105 | Wrong Technique In Drug Usage Process | 5 | 1.0 | 1.0 | no signal |
| 106 | Accidental Exposure To Product | 11 | 0.8 | 0.8 | no signal |